This may explain Ketamir-2's ability to maintain CNS activity despite its lower NMDA receptor affinity. "We are honored to see our foundational research on Ketamir-2 published in a high-impact ...

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company’s drug ...

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received marketing authorization for the product Oxybutynin hydrochloride Oral Solution from UK Medicines & Healthcare Products ...

Shares of Suven Life Sciences and Camlin Fine Sciences hit their respective life-time highs, surging up to 9 per cent on the ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments ...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed. Four years ...

Pfizer said in a statement that it felt “placing this set of neuroscience assets…in a company with dedicated focus and expertise in CNS was the optimal next step.” In January, Pfizer said it ...

Students pursuing the Bachelor of Arts (B.A.) degree cannot use foreign culture courses to fulfill their foreign language requirement. The B.A. degree will count foreign language credit gained through ...

South Korean LG CNS has announced a partnership with US-based Skild AI to develop industrial humanoid robot solutions aimed at automating complex physical tasks. The agreement, announced on Tuesday, ...

Press Telegram from February 28, 2025 to March 2, 2025 View All Obituaries February 21, 2025 Dr. Cal Farmer, Ph.D. Long Beach, CA ...

This exemplary study has been published in world-renowned Wiley’s publication journal, CNS Neuroscience & Therapeutics. On this occasion, Acharya Balkrishna stated that in Parkinson’s disease, not ...